Asian biotech start-up Engine Biosciences has secured $10 million in funding. The company, which applies machine learning to genomics for drug discovery, secured the funding in a round led by Danhua Venture Capital and 6 Dimensions Capital. In a statement, Engine Biosciences confirmed that the funding will help with the development of its drug discovery platform and the expansion of its teams in Singapore and San Francisco. Dr. Leon Chen, CEO of 6 Dimensions Capital, said: "We expect the company's AI platform will lead to insightful information in complex diseases' pathways".
Asian biotech start-up Engine Biosciences has secured $10m in funding. The company, which applies machine learning to genomics for drug discovery, secured the funding in a round led by Danhua Venture Capital and 6 Dimensions Capital. In a statement, Engine Biosciences confirmed that the funding will help with the development of its drug discovery platform and the expansion of its teams in Singapore and San Francisco. Dr. Leon Chen, CEO of 6 Dimensions Capital, said: "We expect the company's AI platform will lead to insightful information in complex diseases' pathways".